7/26/2013

The FDA approved American Regent's ferric carboxymaltose injection, or Injectafer, to treat iron deficiency anemia in adults. It is indicated for patients with nondialysis-dependent chronic kidney disease and in those who are intolerant or nonresponsive to oral iron. The drug is sold in Europe as Ferinject.

Related Summaries